Disposition · Activity not yet classified
LifeSync
Transaction overview
Reported completed
Exact closing date not established.
On February 26, 2025, Capitala reported that it had fully exited its equity position in LifeSync through the sale to Amphenol. Capitala had invested alongside HealthEdge Investment Partners. The exact closing day is not specified.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Capitala Group Completes Sale of LifeSync to Amphenol ↗
Capitala Group · Published Feb 26, 2025
On February 26, 2025, Capitala reported that it had fully exited its equity position in LifeSync through the sale to Amphenol. Capitala had invested alongside HealthEdge Investment Partners. The exact closing day is not specified.
- Capitala advisory services disclosures ↗
Capitala Group · Publication date not stated
The current disclosures identify the Capitala advisory-services entity with the spelling Capital Private Advisors, LLC. The linked privacy policy supplies the exact legal name Capitala Private Advisors, LLC. These current pages support sponsor-manager identity only, not direct balance-sheet ownership.
- Capitala Private Advisors privacy policy ↗
Capitala Group · Publication date not stated
The current privacy policy explicitly identifies Capitala Private Advisors, LLC as the Advisor and covers its employees and affiliated or closely related companies. Together with the advisory-services disclosures this supports limited sponsor-manager attribution; it does not assert the adviser itself held the investment on its balance sheet.